Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

CCA masthead new1

Clinical Cardiology Alert – May 1, 2024

May 1, 2024

View Archives Issues

  • Clinical Features of Tachyarrhythmia-Induced Cardiomyopathy

    A prospective observational study of patients with left ventricular dysfunction without known cause and tachyarrhythmias has shown that restoration of sinus rhythm significantly improves left ventricular function in more than 80% of such patients by six months and, initially, normal left ventricular size can be predictive of this response.

  • Another Hemodynamic Variant of Aortic Stenosis

    A large, retrospective, observational study of patients with aortic valve gradients in the severe aortic stenosis range but with aortic valve areas in the moderate range has shown that such patients are not uncommon. Their prognosis is similar to patients with high-gradient severe aortic stenosis.

  • Combined TAVR and LAAO Studied in a Randomized Controlled Trial

    In this randomized controlled trial of patients with atrial fibrillation undergoing transcatheter aortic valve replacement (TAVR), concomitant left atrial appendage occlusion at the time of TAVR was noninferior to TAVR plus medical therapy for a combined endpoint of death, stroke, and major bleeding at two years.

  • Can Pulmonary Artery Pressure Help in the Decision to Operate in Chronic Aortic Regurgitation?

    A large tertiary center retrospective observational study of patients with moderate to severe aortic regurgitation showed that 14% had significant pulmonary hypertension (PH) and that it was associated with symptoms and higher mortality. Aortic valve replacement abrogated PH in most patients by hospital discharge and improved survival regardless of the presence of PH.

  • Is Artificial Intelligence Coming for Your Job?

    A retrospective analysis of plain chest X-ray images in the medical record using deep learning in patients suitable for risk assessment for atherosclerotic cardiovascular disease (ASCVD) has shown similar results as the American College of Cardiology/American Heart Association ASCVD risk calculator for determining who is at sufficient risk to consider statin therapy.